Literature DB >> 8773218

Tardive dyskinesia in non-western countries: a review.

A K Pandurangi1, Y A Aderibigbe.   

Abstract

Tardive dyskinesia (TD) is a well-described adverse effect of treatment with neuroleptics. Studies from non-western countries are sparse and those that exist are not well publicized. We analyzed prevalence data on TD, published in English or French, and carried out in countries in Africa and Asia through December 1993. The estimated prevalence of TD among African subjects was 24% and among Asian subjects 17.2091. Both rates are in the middle range when compared with the western prevalence rates of 10-50%. Long-term hospitalization and older age were risk factors associated with TD. Female gender did not emerge as a risk factor. Also, several Asian studies showed that subjects with TD were taking lower doses of neuroleptics than subjects without TD. Prospective and controlled cross-cultural studies of TD are recommended for better understanding of associated risk factors and primary prevention.

Entities:  

Mesh:

Year:  1995        PMID: 8773218     DOI: 10.1007/bf02191814

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  35 in total

1.  A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients.

Authors:  K M Lin; R E Poland; I Nuccio; K Matsuda; N Hathuc; T P Su; P Fu
Journal:  Am J Psychiatry       Date:  1989-10       Impact factor: 18.112

2.  A rating scale for tardive dyskinesia.

Authors:  G M Simpson; J H Lee; B Zoubok; G Gardos
Journal:  Psychopharmacology (Berl)       Date:  1979-08-08       Impact factor: 4.530

3.  Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.

Authors:  S Mukherjee; A M Rosen; C Cardenas; V Varia; S Olarte
Journal:  Arch Gen Psychiatry       Date:  1982-04

4.  Prevalence of persistent abnormal involuntary movements among patients in a Nigerian long-stay psychiatric unit.

Authors:  A O Odejide
Journal:  Int Pharmacopsychiatry       Date:  1980

5.  Prevalence of tardive dyskinesia, tardive dystonia, and respiratory dyskinesia among Chinese psychiatric patients in Hong Kong.

Authors:  H Chiu; P Shum; J Lau; L Lam; S Lee
Journal:  Am J Psychiatry       Date:  1992-08       Impact factor: 18.112

6.  Gender differences in tardive dyskinesia: a critical review of the literature.

Authors:  R Yassa; D V Jeste
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

7.  Tardive dyskinesia in northern Israel: preliminary study.

Authors:  M Schwartz; H Silver; I Tal; B Sharf
Journal:  Eur Neurol       Date:  1993       Impact factor: 1.710

8.  A survey of tardive dyskinesia in psychiatric inpatients in Japan.

Authors:  Y Koshino; S Madokoro; T Ito; T Horie; M Mukai; K Isaki
Journal:  Clin Neuropharmacol       Date:  1992-02       Impact factor: 1.592

9.  Haloperidol concentrations elevated in Chinese patients.

Authors:  S G Potkin; Y Shen; H Pardes; B H Phelps; D Zhou; L Shu; E Korpi; R J Wyatt
Journal:  Psychiatry Res       Date:  1984-06       Impact factor: 3.222

10.  Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan.

Authors:  R L Binder; H Kazamatsuri; T Nishimura; D E McNiel
Journal:  Am J Psychiatry       Date:  1987-11       Impact factor: 18.112

View more
  1 in total

1.  High dose pyridoxine for the treatment of tardive dyskinesia: clinical case and review of literature.

Authors:  Musa U Umar; Aliyu A Isa; Asmaul H Abba
Journal:  Ther Adv Psychopharmacol       Date:  2015-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.